InfuSystems Holdings Inc INFU
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $13.49
- Day Range
- $13.21–13.75
- 52-Week Range
- $7.29–13.85
- Bid/Ask
- $13.15 / $13.99
- Shares Outstanding
- 19.92M
- Market Cap
- $264.30M
- Volume/Avg
- 76,711 / 143,779
Key Statistics
- Price/Earnings (Normalized)
- 36.76
- Price/Sales
- 1.94
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 3.50%
Company Profile
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 473
- Website
- http://www.infusystem.com
Valuation
|
Metric
|
INFU
|
|---|---|
Price/Earnings (Normalized) | 36.76 |
Price/Book Value | 4.47 |
Price/Sales | 1.94 |
Price/Cash Flow | 9.74 |
Price/Earnings
INFU
Financial Strength
|
Metric
|
INFU
|
|---|---|
Quick Ratio | 1.84 |
Current Ratio | 2.50 |
Interest Coverage | 12.10 |
Quick Ratio
INFU
Profitability
|
Metric
|
INFU
|
|---|---|
Return on Assets (Normalized) | 11.44% |
Return on Equity (Normalized) | 19.92% |
Return on Invested Capital (Normalized) | 14.81% |
Return on Assets
INFU
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|k?KZxd# | LOCK|jMYC | $170B | |||
| Medtronic PLC
MDT
| LOCK|d!?dHM | LOCK|z?#J | $111B | |||
| Stryker Corp
SYK
| LOCK|VKS>^g$ | LOCK|<h# | $107B | |||
| Boston Scientific Corp
BSX
| LOCK|S^$nMm | LOCK|s!^# | $61B | |||
| Edwards Lifesciences Corp
EW
| LOCK|#<!S>$$s | LOCK|dB^@$ | $50B | |||
| DexCom Inc
DXCM
| LOCK|npR#?sR# | LOCK|><M&z | $31B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|N?@yZC | LOCK|YMQ | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|>? | LOCK|^DY | $23B | |||
| Steris PLC
STE
| LOCK|chXTf! | LOCK|BQy?y | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|ZPmjrWHn | LOCK|HD# | $17B |
United States